share_log

Champions Oncology Q1 EPS $(0.02) Misses $0.01 Estimate, Sales $13.74M Beat $13.19M Estimate

Benzinga Real-time News ·  Sep 8, 2022 16:02

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 300 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $13.74 million which beat the analyst consensus estimate of $13.19 million by 4.21 percent. This is a 22.15 percent increase over sales of $11.25 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment